/Sponsor / Executive Profile

Daniel Geffken

Executive

Aggregate Capital Deployment Matrix

Professional Biography

Daniel Geffken has been our Chief Financial Officer since October 2020. He has been an executive in the life sciences industry since 1993.

Total Capital Deployed

$327,900,000

Active / Searching Capital:
-

Transaction Volume

2 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

0.0%

Professional Network Intelligence

Frequent Underwriters

Frequent Associates

Top Sectors

  • Immunotherapy1 Deals
  • biopharmaceutical1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
CERO
Phoenix Biotech Acquisition Corp.
closed
158.1M
$2.00
1/2Sep 2021Done-ImmunotherapyCantor Fitzgerald & Co.
EFTR
Locust Walk Acquisition Corp.
closed
169.8M
$10.00
1/3Dec 2020Done-biopharmaceuticalCantor Fitzgerald & Co.